Adawi Kamal bought FATE
October 20, 2025 · Form 4 insider transaction
Adawi Kamal bought 375,000 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
375,000
Price
$0.00
Total value
N/A
InsiderAdawi Kamal
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 20, 2025
Filing dateOctober 21, 2025
Shares owned after375,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest as to 25% of the underlying shares on October 20, 2026 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.